Press release -

Genycell Biotech appointed as distributor in Spain & Portugal

Genycell Biotech was founded in 2001 as a supplier of products, services and technologies for basic and applied research within the areas of life science, biotechnology and biomedicine.

“We are delighted at the new partnership with Halo Genomics”, said Javier Martin, CEO of Genycell Biotech. “The Selector and HaloPlex PCR brands perfectly complement our existing portfolio of high quality products for life science research applications”.

“Genycell Biotech has the resources and in-country knowledge to provide detailed product expertise and excellent support to our growing customer base in Spain and Portugal.” said Maria Hjortsmark, Chief Business Officer of Halo Genomics.

Halo Genomics’ products were promoted at the 8th European Cytogenetics Conference ( in Porto, Portugal, earlier this month.

Learn more about Genycell at

Related links


  • Science, technology


  • library-free targeted resequencing
  • targeted resequencing
  • target enrichment
  • sample preparation
  • sample enrichment
  • resequencing
  • next generation sequencing (ngs).
  • biotechnology

Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.


Olle Ericsson

Press contact CEO, Co-founder +46 18 495 31 20

Related content